Edmonton Company Entos Developing DNA Vaccine against COVID-19 (IMAGE)
Caption
John Lewis (left), CEO of Entos Pharmaceuticals and oncology professor at the U of A, says the company is working on a DNA-based vaccine against COVID-19 that would be easier to mass-produce than traditional vaccines and would work without needing an infectious agent.
Credit
Faculty of Medicine & Dentistry, University of Alberta
Usage Restrictions
None
License
Licensed content